Cargando…

Control of Epstein-Barr virus infection in vitro by T helper cells specific for virion glycoproteins

Epstein-Barr virus (EBV) establishes lifelong persistent infections in humans by latently infecting B cells, with occasional cycles of reactivation, virus production, and reinfection. Protective immunity against EBV is mediated by T cells, but the role of EBV-specific T helper (Th) cells is still po...

Descripción completa

Detalles Bibliográficos
Autores principales:	Adhikary, Dinesh, Behrends, Uta, Moosmann, Andreas, Witter, Klaus, Bornkamm, Georg W., Mautner, Josef
Formato:	Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 2006
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2118290/ https://www.ncbi.nlm.nih.gov/pubmed/16549597 http://dx.doi.org/10.1084/jem.20051287

Ejemplares similares

Immunodominance of Lytic Cycle Antigens in Epstein-Barr Virus-Specific CD4+ T Cell Preparations for Therapy
por: Adhikary, Dinesh, et al.
Publicado: (2007)

Virus and Autoantigen-Specific CD4+ T Cells Are Key Effectors in a SCID Mouse Model of EBV-Associated Post-Transplant Lymphoproliferative Disorders
por: Linnerbauer, Stefanie, et al.
Publicado: (2014)

Immunoinformatic Analysis Reveals Antigenic Heterogeneity of Epstein-Barr Virus Is Immune-Driven
por: Cirac, Ana, et al.
Publicado: (2021)

Epstein-Barr Virus Exploits the Secretory Pathway to Release Virions
por: Nanbo, Asuka
Publicado: (2020)

An Epstein-Barr Virus Anti-Apoptotic Protein Constitutively Expressed in Transformed Cells and Implicated in Burkitt Lymphomagenesis: The Wp/BHRF1 Link
por: Kelly, Gemma L., et al.
Publicado: (2009)

Epstein-Barr viral miRNAs inhibit antiviral CD4(+) T cell responses targeting IL-12 and peptide processing
por: Tagawa, Takanobu, et al.
Publicado: (2016)

Revisiting IgG Antibody Reactivity to Epstein-Barr Virus in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Its Potential Application to Disease Diagnosis
por: Sepúlveda, Nuno, et al.
Publicado: (2022)

Epstein-Barr Virus BBLF1 Mediates Secretory Vesicle Transport to Facilitate Mature Virion Release
por: Uddin, Md Kamal, et al.
Publicado: (2023)

Evaluation of T-activated proteins as recall antigens to monitor Epstein–Barr virus and human cytomegalovirus-specific T cells in a clinical trial setting
por: Körber, Nina, et al.
Publicado: (2020)

Epstein-Barr Virus Glycoprotein Antibody Titers and Risk of Nasopharyngeal Carcinoma
por: Coghill, Anna E, et al.
Publicado: (2022)

Follicular Helper and Regulatory T Cells Drive the Development of Spontaneous Epstein–Barr Virus Lymphoproliferative Disorder
por: Ahmed, Elshafa Hassan, et al.
Publicado: (2023)

Micro RNAs of Epstein-Barr Virus Promote Cell Cycle Progression and Prevent Apoptosis of Primary Human B Cells
por: Seto, Eri, et al.
Publicado: (2010)

Epstein–Barr virus particles induce centrosome amplification and chromosomal instability
por: Shumilov, Anatoliy, et al.
Publicado: (2017)

Subcellular Distribution of BALF2 and the Role of Rab1 in the Formation of Epstein-Barr Virus Cytoplasmic Assembly Compartment and Virion Release
por: Chao, Tsung-Yu, et al.
Publicado: (2023)

Retroviral Env Glycoprotein Trafficking and Incorporation into Virions
por: Murakami, Tsutomu
Publicado: (2012)

Incorporation of Spike and Membrane Glycoproteins into Coronavirus Virions
por: Ujike, Makoto, et al.
Publicado: (2015)

The Epstein-Barr Virus
por: Payne, L. N.
Publicado: (1980)

Association between Antibody Responses to Epstein-Barr Virus Glycoproteins, Neutralization of Infectivity, and the Risk of Nasopharyngeal Carcinoma
por: Zhu, Qian-Ying, et al.
Publicado: (2020)

Epstein - Barr virus Pneumonitis
por: McManus, Terence E, et al.
Publicado: (2009)

Epstein–Barr virus vaccines
por: Cohen, Jeffrey I
Publicado: (2015)

Epstein–barr virus vaccines
por: Cohen, Jeffrey I
Publicado: (2015)

Epstein-Barr virus and skin
por: Sangueza-Acosta, Martin, et al.
Publicado: (2018)

Epstein-Barr Virus Gastritis
por: Oki, Masayuki, et al.
Publicado: (2017)

Resurrecting Epstein–Barr Virus
por: Paganelli, Roberto
Publicado: (2022)

Correlation of interleukin-6 with Epstein–Barr virus levels in COVID-19
por: Lehner, Georg Franz, et al.
Publicado: (2020)

A Diverse Repertoire of CD4 T Cells Targets the Immediate-Early 1 Protein of Human Cytomegalovirus
por: Ameres, Stefanie, et al.
Publicado: (2015)

Association of the Epstein-Barr virus with breast cancer: in vivo and in vitro studies
por: Bonnet-Duqeynoy, M, et al.
Publicado: (2001)

The Epstein-Barr Virus Glycoprotein gp150 Forms an Immune-Evasive Glycan Shield at the Surface of Infected Cells
por: Gram, Anna M., et al.
Publicado: (2016)

Potential Cellular Functions of Epstein-Barr Nuclear Antigen 1 (EBNA1) of Epstein-Barr Virus
por: Smith, Danielle Westhoff, et al.
Publicado: (2013)

Epstein-Barr Virus Genome Deletions in Epstein-Barr Virus-Positive T/NK Cell Lymphoproliferative Diseases
por: Wongwiwat, Wiyada, et al.
Publicado: (2022)

Retromer Regulates HIV-1 Envelope Glycoprotein Trafficking and Incorporation into Virions
por: Groppelli, Elisabetta, et al.
Publicado: (2014)

Flow virometry analysis of envelope glycoprotein conformations on individual HIV virions
por: Arakelyan, Anush, et al.
Publicado: (2017)

Influence of Different Glycoproteins and of the Virion Core on SERINC5 Antiviral Activity
por: Diehl, William E., et al.
Publicado: (2021)

Epstein-Barr Virus and Human Cancer
por: Young, Lawrence
Publicado: (2002)

An Epstein-Barr virus-associated superantigen
Publicado: (1996)

Macular Amyloidosis and Epstein-Barr Virus
por: Nahidi, Yalda, et al.
Publicado: (2016)

Epstein-Barr virus infection mechanisms
por: Chesnokova, Liudmila S., et al.
Publicado: (2014)

Epstein-Barr Virus Neurologic Complications
por: Millichap, J. Gordon
Publicado: (2015)

Epstein–Barr virus latent genes
por: Kang, Myung-Soo, et al.
Publicado: (2015)

Epstein-Barr virus and nasopharyngeal carcinoma
por: Young, Lawrence S., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ckkqoa9km8qph69v0kb1331erj